Literature DB >> 16169170

The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells.

Kui-Kui Ren1, Hong-Zhong Wang, Li-Ping Xie, Da-Wei Chen, Xing Liu, Juan Sun, Yan-Cheng Nie, Rong-Qing Zhang.   

Abstract

Oridonin, a diterpenoid isolated from Rabdosia rubescens (Hemsl.) Hara, is currently one of the most important traditional Chinese herbal medicines. We investigated the anti-proliferation effect of oridonin on the cultured murine melanoma cell line K1735M2. The growth inhibition activity of oridonin for K1735M2 cells occurred in a time- and dose-dependent manner (IC50 was 7.4+/-0.6 microM). Further studies showed that these inhibition effects were associated with dose-dependent G2/M phase arrest and differentiation induction. Detection of morphological observation showed that oridonin could induce K1735M2 cells to produce dendrite-like structures. The results of the migration indicated that oridonin affected motility of K1735M2 cells in a dose-dependent manner. These results suggested that oridonin is a potential candidate for melanoma cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169170     DOI: 10.1016/j.jep.2005.07.020

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  18 in total

Review 1.  Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies.

Authors:  Chun-Feng Wang; Zhen-Yu Wang; Ji-Yu Li
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

Review 2.  Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin.

Authors:  Wei Tian; Si-Yu Chen
Journal:  Chin J Integr Med       Date:  2013-04-02       Impact factor: 1.978

3.  Genomic and in vivo evidence of synergy of a herbal extract compared to its most active ingredient: Rabdosia rubescens vs. oridonin.

Authors:  Angela M Wong; Yanjung Zhang; Kelly Kesler; Max Deng; Lucas Burhenn; David Wang; Aune Moro; Zhaoping Li; David Heber
Journal:  Exp Ther Med       Date:  2010-09-01       Impact factor: 2.447

4.  Oridonin suppress cell migration via regulation of nonmuscle myosin IIA.

Authors:  Yin-Chao Li; Mo-Ran Sun; Yi-Hong Zhao; Xian-Zu Fu; Hai-Wei Xu; Ji-Feng Liu
Journal:  Cytotechnology       Date:  2014-10-09       Impact factor: 2.058

5.  ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells.

Authors:  Duo-te Cai; Hua Jin; Qi-Xing Xiong; Wei-Guang Liu; Zhi-gang Gao; Gui-xiong Gu; Yu-hui Qiu
Journal:  Mol Cell Biochem       Date:  2013-04-12       Impact factor: 3.396

6.  The cell death of C6 astrocytoma cells induced by oridonin and its mechanism.

Authors:  Bo Yin; Hansong Sheng; Jian Lin; Hui Zhou; Nu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29

7.  Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells.

Authors:  Feng-Hou Gao; Feng Liu; Wei Wei; Li-Bin Liu; Mang-Hua Xu; Zhu-Ying Guo; Wei Li; Bin Jiang; Ying-Li Wu
Journal:  Int J Mol Med       Date:  2012-01-24       Impact factor: 4.101

8.  Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line.

Authors:  Zhen Zhang; Xiumei Zhang; Wei Xue; Yuna Yangyang; Derong Xu; Yunxue Zhao; Haiyan Lou
Journal:  Int J Nanomedicine       Date:  2010-10-05

9.  Kaurenic acid: Evaluation of the in vivo and in vitro antitumor activity on murine melanoma.

Authors:  Miriam C Sosa-Sequera; Miguel Chiurillo; Jaime Moscoso; Josefina Dolinar; Omar Suarez; Natalia Neira; Hernan Mendoza; María Rivero-Paris
Journal:  Indian J Pharmacol       Date:  2011-11       Impact factor: 1.200

10.  RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.

Authors:  Jie Xu; Ji-Hui Zhao; Ying Liu; Nian-Ping Feng; Yong-Tai Zhang
Journal:  Int J Nanomedicine       Date:  2012-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.